Abstract
The Molecular Adsorbent Recirculating System (MARS) is a nonbiological liver support method based on the principles of dialysis, filtration, and adsorption. It allows the safe and efficient removal of both albumin-bound and water-soluble toxic metabolites, including ammonia, aromatic amino acids, tryptophan, and related phenolic and indolic products, as well as benzodiazepines. A well-documented effect of the treatment is the improvement of the hemodynamic situation of decompensated chronic patients. Systemic vascular resistance, mean arterial pressure, cerebral blood flow, and cerebral oxygen consumption increased significantly. The degree of hepatic encephalopathy decreased significantly. Increased intracranial pressure could be normalized in both chronic and fulminant liver failure. In three randomized clinical trials significant improvement of survival could be demonstrated. In a model of murine neuronal networks cultured on multi-microelectrode array plates and incubated with plasma from liver failure patients, a normalization of the spike and burst pattern could be observed, if plasma samples from MARS-treated patients before and after treatment were compared. In conclusion, MARS significantly improves central nervous system functions. It can serve as a model for the further investigation of the role of protein-bound substances in hepatic encephalopathy and cerebral hemodynamics.
Similar content being viewed by others
REFERENCES
Ash, S.R., Steczko, J., Knab, W.R., Blake, D.E., Carr, D.J., Harker, K.D., et al. (2000). Push-pull sorbent-based pheresis and hemodiabsorption in the treatment of hepatic failure: Preliminary results of a clinical trial with the BioLogic-DTPF System. Ther. Apher. 4:218-228.
Awad, S.S., Rich, P.B., Kolla, S., Younger, J.G., Reickert, C.A., Downing, V.P., et al. (1997). Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin. ASAIO J. 43:M745-M749.
Awad, S.S., Swaniker, F., Magee, J., Punch, J., and Bartlett, R.H. (2001). Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery 130:354-362.
Blei, A.T., and Córdoba, J. (2001). Hepatic encephalopathy. Am. J. Gastroenterol. 96:1968-1976.
Butterworth, R.F. (2000). Hepatic encephalopathy: A neuropsychiatric disorder involving multiple neurotransmitter systems. Curr. Opin. Neurol. 13:721-727.
Cordoba, J., Blei, A.T., and Mujais, S. (1996). Determinants of ammonia clearance by hemodialysis. Artif. Organs 20:800-803.
El-Banayosy, A., Kizner, L., Notohamiprodjo, M., Schüler, V., Bergmeier, S., and Körfer, R. (2001). Single center randomized study to evaluate MARS technique on patients with hyperbilirubinemia following cardiogenic shock after cardiac surgery (abstract). Abstractbook. In: 3rd International Symposium on Albumin Dialysis in Liver Disease, Sept. 7-9, 2001, Rostock, Germany.
Ellis, A.J., Hughes, R.D., Nicholl, D., Langley, P.G., Wendon, J.A., O'Grady, J.G., et al. (1999). Temporary extracorporeal liver support for severe acute alcoholic hepatitis using the BioLogic-DT. Int. J. Artif. Organs 22:27-34.
Fischer, J.E., Funovics, J.M., Aguirre, A., James, J.H., Keane, J.M., Wesdorp, R.I.C., et al. (1975). The role of plasma amino acids in hepatic encephalopathy. Surgery 78:276-290.
Gaspari, R., Pennisi, M.A., Mignani, V., Gasbarrini, A., Mercurio, G., Di Campli, C., et al. (2001). Artificial liver support as a bridge to orthotopic liver transplantation in a case of acute liver dysfunction on non-alcoholic steatohepatitis (NASH). Z. Gastroenterol. 39(Suppl. 2):15-17.
Greco, A.V., Mingrone, G., Favuzzi, A., Bertuzzi, A., Gandolfi, A., DeSmet, R., et al. (2000). Subclinical hepatic encephalopathy: Role of tryptophan binding to albumin and the competition with indole-3-acetic acid. J. Investig. Med. 48:274-280.
Gross, G.W. (1994). Internal dynamics of randomized mammalian neuronal networks in culture. In: Stenger, D.A., and McKenna, T.M. (eds.), Enabling Technologies for Cultured Neural Networks, Academic Press, New York, pp. 277-317.
Hughes, R.D., and Williams, R. (1993). Use of sorbent columns and haemofiltration in fulminant hepatic failure. Blood Purif. 11:163-169.
Jalan, R., Kapoor, D., Steiner, C., and Williams, R. (2001). MARS in decompensated alcoholic liver disease with multi-organ failure. Z. Gastroenterol. 39(Suppl. 2):12.
Kaplan, A.A., and Epstein, M. (1997). Extracorporeal blood purification in the management of patients with hepatic failure. Semin. Nephrol. 17:576-582.
Keller, F., Heinze, H., Jochimsen, F., Passfall, J., Schuppan, D., and Buttner, P. (1995). Risk factors and outcome of 107 patients with decompensated liver disease and acute renal failure (including 26 patients with hepatorenal syndrome): The role of hemodialysis. Ren. Fail. 17:135-146.
Klammt, S., Brinckmann, B., Mitzner, S., Munzert, E., Loock, J., Stange, J., et al. (2001a). Albumin Binding Capacity (AbiC) is reduced in commercially available Human Serum Albumin preparations with stabilizers. Z. Gastroenterol. 39(Suppl. 2):24-27.
Klammt, S., Brinckmann, B., Mitzner, S., Munzert, E., Loock, J., Stange, J., et al. (2001b). Assessment of albumin binding capacity for characterization of albumin-transport function by a new method [Abstract]. J. Hepatol. 34(Suppl. 1):197.
Kramer, L., Gendo, A., Madl, C., Mullen, K.D., Kaminski-Russ, K., Sunder-Plassmann, G., et al. (2001). A controlled study of sorbent suspension dialysis in chronic liver disease and hepatic encephalopathy. Int. J. Artif. Organs 24:434-442.
Kreymann, B., Seige, M., Schweigart, U., Kopp, K.F., and Classen, M. (1999). Albumin dialysis: Effective removal of copper in a patient with fulminant Wilson disease and successful bridging to liver transplantation: A new possibility for the elimination of protein-bound toxins. J. Hepatol. 31:1080-1085.
Loock, J., Peters, E., Stange, J., Mitzner, S., Peszinski, P., Klammt, S., et al. (1997). Change of human serum albumin amino acid patterns (Fischer-index) during a new dialysis treatment for liver failure (MARS) [Abstract]. Int. J. Artif. Organs 20:500.
Loock, J., Stange, J., Mitzner, S., Schmidt, R., Gramowski, A., Schiffmann, D., et al. (2001). Influence of albumin dialysis (MARS) on the neuronal network activity. Z. Gastroenterol. 39(Suppl. 2):28-32.
Loock, J., Peters, E., Heemann, U., Klammt, S., Peszynski, P., Schmidt, R., et al. (in press). Effect of recirculation of albumin dialysis (MARS) onto plasma amino acid dysbalance in liver failure-Comparison to non-recirculating albumin dialysis and renal replacement therapy [Abstract]. J. Hepatol.
Mathias, R.S., Kostiner, D., and Packman, S. (2001). Hyperammonemia in urea cycle disorders: Role of the nephrologist. Am. J. Kidney Dis. 37:1069-1080.
Mitzner, S., and Stange, J. (1995). Cell-free artificial liver support-A critical review. In: Körner, M.M., and Körfer, R. (eds.), Current Aspects and Concepts of Nursing, Coordinating, Bridging and Rehabilitation in Organ Transplantation, Elsevier Science B.V., Amsterdam, pp. 81-88.
Mitzner, S., Stange, J., Klammt, S., Risler, T., Erley, C.M., Bader, B.D., et al. (2000). Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: Results of a prospective, controlled clinical trial. Liver Transpl. 6:277-286.
Mitzner, S.R., Stange, J., Klammt, S., Peszynski, P., Schmidt, R., and Noeldge-Schomburg, G. (2001a). Extracorporeal detoxification using the molecular adsorbent recirculating system for critically ill patients with liver failure. J. Am. Soc. Nephrol. 12(Suppl. 17):S75-S82.
Mitzner, S., Stange, J., Klammt, S., Peszynski, P., and Schmidt, R. (2001b). Albumin dialysis using the MARS system. Curr. Opin. Nephrol. Hypertens. 10:777-783.
Norenberg, M.D. (1996). Astrocytic-ammonia interactions in hepatic encephalopathy. Semin. Liver Dis. 16:245-253.
Notohamiprodjo, M., Kizner, L., El-Banayosy, A., Schüller, V., Bergmeier, S., and Körfer, R. (2001a). Use of the MARS system in liver failure after heart surgery (in German). J. Anästh. Intensivbehandl. 8:96-97.
Notohamiprodjo, M., Banayosy, A., Kizner, L., Schüller, V., and Körfer, R. (2001b). MARS treatment: One year experience with MARS-therapy in patients with multiple organ failure in Cardiac Center Bad Oeyenhausen [Abstract]. Z. Gastroenterol. 39(Suppl. 2):51.
Novelli, G., Rossi, M., Pretagostini, R., Poli, L., Peritore, D., Berloco, P., et al. (2001). Use of MARS in the treatment of acute liver failure: Preliminary monocentric experience. Transplant. Proc. 33:1942-1944.
Oliviero, A., Mercurio, G., Pilato, F., Accurso, A., Saturno, E., Pennisi, M.A., et al. (2001). Motor cortex excitability in severe liver failure: Effects of Molecular Adsorbent Recycling System [Abstract]. Z. Gastroenterol. 39(Suppl. 2):47.
Peszynski, P., Stange, J., Mitzner, S., Klammt, S., Majcher-Peszynska, J., Wacke, R., et al. (2001). Removal of benzodiazepine-like substances as a cause of improvement of hepatic encephalopathy during albumin dialysis. Z. Gastroenterol. 39(Suppl. 2):53.
Siewert-Delle, A., Henriksson, B.A., and Bäckman, L. (2001). Albumin dialysis with the MARS (Molecular Adsorbent Recirculating System) for a patient with acute liver failure due to paracetamol intoxication: A case report [Abstract]. Z. Gastroenterol. 39(Suppl. 2):48.
Sorkine, P., Ben Abraham, R., Szold, O., Biderman, P., Kidron, A., Merchav, H., et al. (2001). Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure. Crit. Care Med. 29:1332-1336.
Splendiani, G., Tancredi, M., Daniele, M., and Giammaria, U. (1990). Treatment of acute liver failure with hemodetoxification techniques. Int. J. Artif. Organs 13:370-374.
Stange, J., Mitzner, S., Ramlow,W., Gliesche, T., Hickstein, H., and Schmidt, R. (1993). A new procedure for the removal of protein bound drugs and toxins. ASAIO J. 39:M621-M625.
Stange, J., Mitzner, S., Risler, T., Erley, C.M., Lauchart, W., Goehl, H., et al. (1999). Molecular Adsorbent Recirculating System (MARS)-Clinical results of a new membrane based blood purification system for bioartificial liver support. Artif. Organs 23:319-330.
Stange, J., Mitzner, S., Klammt, S., Freytag, J., Peszynski, P., Loock, J., et al. (2000). Liver support by extracorporeal blood purification-A clinical observation. Liver Transpl. 6:603-613.
Stange, J., Mitzner, S.R., and Hassanein, T. (2001a). Albumin dialysis as liver support therapy in acute on chronic hepatic failure-Outcome reports from 11 centers. In: 4th Congress of the European Chapter of the International Hepato-Pancreato-Biliary Association, Monduzzi Editore SpA, Bologna, pp. 55-57.
Stange, J., Mitzner, S., Klammt, S., Loock, J., Treichel, U., Gerken, G., et al. (2001b). New extracorporeal liver support for chronic liver disease complicated by cholestasis-Results of a prospective controlled randomized two center trial [Abstract]. J. Hepatol. 34(Suppl. 1):45.
Steczko, J., Bax, K.C., and Ash, S.R. (2000). Effect of hemodiabsorption and sorbent-based pheresis on amino acid levels in hepatic failure. Int. J. Artif. Organs 23:375-388.
Ullerich, H., Avenhaus,W., Menzel, J., Lerch, M., and Domschke,W. (2001). Employment of MARS (Molecular Adsorbent Recycling System) for the replacement of liver detoxification function up to orthotopic liver transplantation [Abstract]. Z. Gastroenterol. 39(Suppl. 2):46.
Rights and permissions
About this article
Cite this article
Mitzner, S., Loock, J., Peszynski, P. et al. Improvement in Central Nervous System Functions During Treatment of Liver Failure with Albumin Dialysis MARS—A Review of Clinical, Biochemical, and Electrophysiological Data. Metab Brain Dis 17, 463–475 (2002). https://doi.org/10.1023/A:1021986624600
Issue Date:
DOI: https://doi.org/10.1023/A:1021986624600